Literature DB >> 28013094

Reasons for death in patients with sepsis and septic shock.

Ari Moskowitz1, Yasser Omar2, Maureen Chase3, Sharukh Lokhandwala4, Parth Patel3, Lars W Andersen5, Michael N Cocchi6, Michael W Donnino7.   

Abstract

PURPOSE: Understanding the underlying cause of mortality in sepsis has broad implications for both clinical care and interventional trial design. However, reasons for death in sepsis remain poorly understood. We sought to characterize reasons for in-hospital mortality in a population of patients with sepsis or septic shock.
MATERIALS AND METHODS: We performed a retrospective review of patients admitted to the intensive care unit with sepsis or septic shock who died during their index admission. Reasons for death were classified into 6 categories determined a priori by group consensus. Interrater reliability was calculated and Fleiss κ reported. The associations between selected patient characteristics (eg, serum lactate) and reason for death were also assessed.
RESULTS: One hundred fifteen patients were included. Refractory shock (40%) and comorbid withdrawal of care (44%) were the most common reasons for death. Overall interrater agreement was substantial (κ = 0.61, P<.01). Lactate was higher in patients who died because of refractory shock as compared with those who died for other reasons (4.7 vs 2.8 mmol/L, P<.01).
CONCLUSION: In this retrospective cohort, refractory shock and comorbid withdrawal of care were the most common reasons for death. Following prospective validation, the classification methodology presented here may be useful in the design/interpretation of trials in sepsis.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Classification; Lactate; Sepsis

Mesh:

Substances:

Year:  2016        PMID: 28013094      PMCID: PMC5588153          DOI: 10.1016/j.jcrc.2016.11.036

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  21 in total

Review 1.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

Review 2.  Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*.

Authors:  Elizabeth K Stevenson; Amanda R Rubenstein; Gregory T Radin; Renda Soylemez Wiener; Allan J Walkey
Journal:  Crit Care Med       Date:  2014-03       Impact factor: 7.598

3.  Implications of Heterogeneity of Treatment Effect for Reporting and Analysis of Randomized Trials in Critical Care.

Authors:  Theodore J Iwashyna; James F Burke; Jeremy B Sussman; Hallie C Prescott; Rodney A Hayward; Derek C Angus
Journal:  Am J Respir Crit Care Med       Date:  2015-11-01       Impact factor: 21.405

4.  Benchmarking the incidence and mortality of severe sepsis in the United States.

Authors:  David F Gaieski; J Matthew Edwards; Michael J Kallan; Brendan G Carr
Journal:  Crit Care Med       Date:  2013-05       Impact factor: 7.598

5.  A randomized trial of protocol-based care for early septic shock.

Authors:  Donald M Yealy; John A Kellum; David T Huang; Amber E Barnato; Lisa A Weissfeld; Francis Pike; Thomas Terndrup; Henry E Wang; Peter C Hou; Frank LoVecchio; Michael R Filbin; Nathan I Shapiro; Derek C Angus
Journal:  N Engl J Med       Date:  2014-03-18       Impact factor: 91.245

Review 6.  Misinterpretation and misuse of the kappa statistic.

Authors:  M Maclure; W C Willett
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

7.  Goal-directed resuscitation for patients with early septic shock.

Authors:  Sandra L Peake; Anthony Delaney; Michael Bailey; Rinaldo Bellomo; Peter A Cameron; D James Cooper; Alisa M Higgins; Anna Holdgate; Belinda D Howe; Steven A R Webb; Patricia Williams
Journal:  N Engl J Med       Date:  2014-10-01       Impact factor: 91.245

8.  Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.

Authors:  Faiez Zannad; Angeles Alonso Garcia; Stefan D Anker; Paul W Armstrong; Gonzalo Calvo; John G F Cleland; Jay N Cohn; Kenneth Dickstein; Michael J Domanski; Inger Ekman; Gerasimos S Filippatos; Mihai Gheorghiade; Adrian F Hernandez; Tiny Jaarsma; Joerg Koglin; Marvin Konstam; Stuart Kupfer; Aldo P Maggioni; Alexandre Mebazaa; Marco Metra; Christina Nowack; Burkert Pieske; Ileana L Piña; Stuart J Pocock; Piotr Ponikowski; Giuseppe Rosano; Luis M Ruilope; Frank Ruschitzka; Thomas Severin; Scott Solomon; Kenneth Stein; Norman L Stockbridge; Wendy Gattis Stough; Karl Swedberg; Luigi Tavazzi; Adriaan A Voors; Scott M Wasserman; Holger Woehrle; Andrew Zalewski; John J V McMurray
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

9.  Causes of death and determinants of outcome in critically ill patients.

Authors:  Viktoria D Mayr; Martin W Dünser; Veronika Greil; Stefan Jochberger; Günter Luckner; Hanno Ulmer; Barbara E Friesenecker; Jukka Takala; Walter R Hasibeder
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

10.  The staging of sepsis: understanding heterogeneity in treatment efficacy.

Authors:  John C Marshall
Journal:  Crit Care       Date:  2005-11-22       Impact factor: 9.097

View more
  16 in total

1.  Leaking chemokines confuse neutrophils.

Authors:  Alex Marki; Klaus Ley
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

2.  The association between tidal volume and neurological outcome following in-hospital cardiac arrest.

Authors:  Ari Moskowitz; Anne V Grossestreuer; Katherine M Berg; Parth V Patel; Sarah Ganley; Marcel Casasola Medrano; Michael N Cocchi; Michael W Donnino
Journal:  Resuscitation       Date:  2017-12-29       Impact factor: 5.262

3.  Premise for Standardized Sepsis Models.

Authors:  Daniel G Remick; Alfred Ayala; Irshad H Chaudry; Craig M Coopersmith; Clifford Deutschman; Judith Hellman; Lyle Moldawer; Marcin F Osuchowski
Journal:  Shock       Date:  2019-01       Impact factor: 3.454

4.  Management of vasopressor induced ischemia.

Authors:  Michael Livesey; Julio J Jauregui; Max C Hamaker; Raymond A Pensy; Christopher G Langhammer; W Andrew Eglseder
Journal:  J Orthop       Date:  2020-10-16

5.  Luteolin alleviates vascular dysfunctions in CLP-induced polymicrobial sepsis in mice.

Authors:  Soya Rungsung; Thakur Uttam Singh; Kirthika Perumalraja; Archana Mahobiya; Meemansha Sharma; Madhu Cholenahalli Lingaraju; Subhashree Parida; Monalisa Sahoo; Dinesh Kumar
Journal:  Pharmacol Rep       Date:  2022-08-08       Impact factor: 3.919

6.  Thiamine in septic shock patients with alcohol use disorders: An observational pilot study.

Authors:  Mathias Johan Holmberg; Ari Moskowitz; Parth Vijay Patel; Anne Victoria Grossestreuer; Amy Uber; Nikola Stankovic; Lars Wiuff Andersen; Michael William Donnino
Journal:  J Crit Care       Date:  2017-08-16       Impact factor: 3.425

7.  Evaluation of the role of sex as a prognostic factor in critically ill adults with sepsis: systematic review protocol.

Authors:  Jesus Lopez-Alcalde; Alba Antequera Martín; Elena Stallings; Alfonso Muriel; Borja Fernández-Félix; Ivan Solà; Rosa Del Campo; Manuel Ponce-Alonso; Federico Gordo; Pilar Fidalgo; Ana Verónica Halperin; Noelia Álvarez-Díaz; Olaya Madrid-Pascual; Gerard Urrutia; Javier Zamora
Journal:  BMJ Open       Date:  2020-05-06       Impact factor: 2.692

8.  MicroRNA-219 alleviates glutamate-induced neurotoxicity in cultured hippocampal neurons by targeting calmodulin-dependent protein kinase II gamma.

Authors:  Ting Wang; Qun Cai; Wen-Jie Yang; Hai-Hua Fan; Jian-Feng Yi; Feng Xu
Journal:  Neural Regen Res       Date:  2018-07       Impact factor: 5.135

Review 9.  Relationship between hemoglobin A1c and serum troponin in patients with diabetes and cardiovascular events.

Authors:  Stjepan Šimić; Tomo Svaguša; Ingrid Prkačin; Tomislav Bulum
Journal:  J Diabetes Metab Disord       Date:  2019-11-11

10.  Independent Risk Factors for Sepsis-Associated Cardiac Arrest in Patients with Septic Shock.

Authors:  Won Soek Yang; Youn-Jung Kim; Seung Mok Ryoo; Won Young Kim
Journal:  Int J Environ Res Public Health       Date:  2021-05-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.